Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Olmesartan Medoxomil Prices, Demand and Supply Overview
Olmesartan Medoxomil prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 81.8/KG in Q1 to USD 86.7/KG by Q2 as firmer imidazole and biphenyltetrazole synthesis intermediate costs and recovering antihypertensive formulation procurement reversed the brief Q4 2025 market correction. Globally, the average rose from USD 57.68/KG in Q1 to USD 61.14/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 61.6-68.8/KG is expected, with continued firming on Middle East supply disruptions and growing antihypertensive and cardiovascular protection sector demand globally.
Olmesartan Medoxomil is the medoxomil ester prodrug of olmesartan, a potent angiotensin II AT1 receptor antagonist of the sartans antihypertensive class, produced by multi-step synthesis from imidazole-4-carboxylic acid and 4-bromomethylbiphenyl-2-carbonitrile building blocks through N-alkylation, medoxomil Mitsunobu esterification, and tetrazole ring formation from the nitrile intermediate. The medoxomil ester is rapidly cleaved by gastrointestinal esterases to release the active olmesartan diacid, which selectively and irreversibly blocks the AT1 receptor subtype, preventing angiotensin II-mediated vasoconstriction with a pharmacodynamic duration enabling once-daily dosing. Olmesartan produces one of the most potent blood pressure reductions among the sartans class at equivalent therapeutic doses, supporting its established position in first-line and step-up combination antihypertensive therapy across diverse adult hypertensive populations globally. Microalbuminuria reduction in diabetic nephropathy, cardiovascular risk reduction, and combination product formulations with amlodipine or hydrochlorothiazide add further demand. Combination product formulations including olmesartan-amlodipine and olmesartan-hydrochlorothiazide fixed-dose combinations further expand the market coverage. Imidazole and biphenyltetrazole synthesis intermediate costs, antihypertensive and diabetic nephropathy prescription volumes, and regional API production capacity in China and India all feed into the price.
Olmesartan Medoxomil Price Forecast for 2026
The balance of supply and demand for Olmesartan Medoxomil through H2 2026 leans moderately firm. Imidazole and biphenyltetrazole synthesis intermediate costs firmed from Middle East chemical supply disruptions. Antihypertensive prescribing volumes and diabetic nephropathy management demand are growing with expanding hypertension treatment access globally.
The main upside risk is synthesis intermediate cost increases alongside accelerating antihypertensive access programme procurement. The main downside risk is continued Chinese and Indian API surplus and generic competition maintaining price pressure below forecast.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 61.6 - 68.8 | Synthesis cost firming and antihypertensive/nephropathy demand |
| United States | 65.4 - 72.6 | Steady antihypertensive and diabetic nephropathy demand holds firm |
| China | 43.8 - 51.0 | Large API capacity keeps it the most affordable |
| Germany | 82.4 - 89.6 | High synthesis and energy costs keep it the most expensive |
| India | 60.0 - 67.2 | Growing antihypertensive and export demand holds a firm middle |
For the Quarter Ending June 2026
Olmesartan Medoxomil Prices Q2 2026:
- United States: USD 70.5/KG
- China: USD 48.9/KG
- Germany: USD 86.7/KG
- India: USD 67.0/KG
Olmesartan Medoxomil Prices in the United States
US Olmesartan Medoxomil prices averaged USD 70.5/KG in Q2 2026, up 6.0% from USD 66.5/KG in Q1 2026. Firmer synthesis intermediate costs and recovering antihypertensive and diabetic nephropathy procurement drove consistent buying through the quarter.
Why did the price of Olmesartan Medoxomil change in Q2 2026 in the United States?
Firmer imidazole and biphenyltetrazole synthesis intermediate costs raised the API production floor. Antihypertensive, diabetic nephropathy, and cardiovascular protection formulation procurement lifted buying. Once-daily dosing programme expansion provided additional support near USD 70.5/KG.
Olmesartan Medoxomil Prices in China
Chinese Olmesartan Medoxomil prices averaged USD 48.9/KG in Q2 2026, up 6.1% from USD 46.1/KG in Q1 2026, the lowest among the tracked markets. Spring antihypertensive export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite domestic API capacity.
Why did the price of Olmesartan Medoxomil change in Q2 2026 in China?
Spring antihypertensive and diabetic nephropathy export and domestic procurement lifted buying. Firmer domestic synthesis intermediate costs raised the production floor. Domestic API capacity kept China the most affordable source.
Olmesartan Medoxomil Prices in Germany
German Olmesartan Medoxomil prices averaged USD 86.7/KG in Q2 2026, up 6.0% from USD 81.8/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Recovering antihypertensive and nephropathy treatment demand maintained buying.
Why did the price of Olmesartan Medoxomil change in Q2 2026 in Germany?
Higher imidazole and biphenyltetrazole synthesis intermediate and energy costs elevated European production economics. Middle East supply disruptions added cost premiums to synthesis chains. Recovering antihypertensive and nephropathy formulation procurement maintained buying near USD 86.7/KG.
Olmesartan Medoxomil Prices in India
Indian Olmesartan Medoxomil prices averaged USD 67.0/KG in Q2 2026, up 6.0% from USD 63.2/KG in Q1 2026. Growing antihypertensive and cardiovascular export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Olmesartan Medoxomil change in Q2 2026 in India?
Growing antihypertensive and diabetic nephropathy export and domestic procurement lifted buying. Firmer synthesis import costs raised the production floor. Cardiovascular protection export demand provided additional support near USD 67.0/KG.
For the Quarter Ending March 2026
Olmesartan Medoxomil Prices Q1 2026:
- United States: USD 66.5/KG
- China: USD 46.1/KG
- Germany: USD 81.8/KG
- India: USD 63.2/KG
Olmesartan Medoxomil Prices in the United States
US prices averaged USD 66.5/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering antihypertensive demand and firming synthesis costs held the market near USD 66.5/KG.
Why did the price of Olmesartan Medoxomil change in Q1 2026 in the United States?
Recovering antihypertensive and diabetic nephropathy procurement maintained buying. Firming synthesis intermediate costs raised the production floor. The market recovered to USD 66.5/KG from the Q4 2025 correction.
Olmesartan Medoxomil Prices in China
Chinese prices averaged USD 46.1/KG in Q1 2026, recovering about 2.0% from Q4 2025. Post-Lunar New Year antihypertensive restocking and firming synthesis costs held the market near USD 46.1/KG.
Why did the price of Olmesartan Medoxomil change in Q1 2026 in China?
Post-Lunar New Year antihypertensive restocking lifted buying. Firming domestic synthesis costs raised the floor. The market recovered to USD 46.1/KG from the Q4 2025 correction.
Olmesartan Medoxomil Prices in Germany
German prices averaged USD 81.8/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering antihypertensive demand and firming synthesis and energy costs held the market near USD 81.8/KG.
Why did the price of Olmesartan Medoxomil change in Q1 2026 in Germany?
Recovering antihypertensive and nephropathy procurement maintained buying. Firming synthesis intermediate and energy costs raised the floor. The market recovered to USD 81.8/KG from the Q4 2025 correction.
Olmesartan Medoxomil Prices in India
Indian prices averaged USD 63.2/KG in Q1 2026, recovering about 1.9% from Q4 2025. Growing antihypertensive and export demand and firming synthesis import costs held the market near USD 63.2/KG.
Why did the price of Olmesartan Medoxomil change in Q1 2026 in India?
Growing antihypertensive and cardiovascular export and domestic procurement maintained buying. Firming synthesis import costs raised the floor. The market recovered to USD 63.2/KG from the Q4 2025 correction.
Quarterly Olmesartan Medoxomil Price Trends
Global Olmesartan Medoxomil prices rose in Q3 2025 on antihypertensive season procurement, dipped in Q4 2025 on synthesis cost moderation, then recovered through Q1 and Q2 2026. The average rose from USD 56.0/KG in Q2 2025 to USD 57.12/KG in Q3, eased to USD 56.55/KG in Q4, then firmed to USD 57.68/KG in Q1 2026 and USD 61.14/KG in Q2 2026, a net gain of about 9.2% over the window. Synthesis intermediate cost cycles and antihypertensive and nephropathy procurement drove the overall pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 61.14 | +6.0% | ↑ Rising |
| Q1 2026 | 57.68 | +2.0% | ↑ Rising |
| Q4 2025 | 56.55 | -1.0% | ↓ Falling |
| Q3 2025 | 57.12 | +2.0% | ↑ Rising |
| Q2 2025 | 56.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
What was Olmesartan Medoxomil Price in 2025?
Olmesartan Medoxomil prices firmed modestly through 2025 on consistent antihypertensive demand. The global average opened near USD 55.6/KG in Q1 2025 and closed at USD 56.55/KG in Q4, a full-year gain of about 1.7%. Synthesis cost dynamics and antihypertensive procurement drove the quarterly pattern.
Olmesartan Medoxomil Prices in the United States in 2025
US prices firmed from about USD 64.5/KG in Q1 2025 to USD 65.2/KG by Q4, a gain of 1.1%. Consistent antihypertensive and diabetic nephropathy demand maintained the modest upward trend.
Olmesartan Medoxomil Prices in China in 2025
Chinese prices firmed from roughly USD 44.7/KG in Q1 2025 to USD 45.2/KG by Q4, a gain of 1.1%. Growing antihypertensive export and domestic demand drove modest firming.
Olmesartan Medoxomil Prices in Germany in 2025
German prices firmed from about USD 79.4/KG in Q1 2025 to USD 80.2/KG by Q4, a gain of 1.0%. Consistent antihypertensive and nephropathy demand and firm synthesis costs supported the market.
Olmesartan Medoxomil Prices in India in 2025
Indian prices firmed from roughly USD 61.4/KG in Q1 2025 to USD 62.0/KG by Q4, a gain of 1.0%. Growing antihypertensive export and domestic demand drove modest firming.
How We Can Help
Expert Market Research: Your Source for Real-Time Olmesartan Medoxomil Price Intelligence
Expert Market Research tracks Olmesartan Medoxomil prices continuously across every major producing and consuming region. The team traces causation through imidazole and biphenyltetrazole synthesis intermediate economics, antihypertensive prescription cycles, and regional API production capacity. Contact Expert Market Research today for Olmesartan Medoxomil pricing data, bespoke market analysis, and strategic procurement advisory.
Pricing Plans
Upto 15% Off
USD
-
$799 $699
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Key Questions Answered in the Report
First-line and combination antihypertensive prescribing with one of the most potent blood pressure reductions among the sartan class at equivalent doses takes the largest share. Microalbuminuria reduction in diabetic nephropathy, cardiovascular risk reduction in hypertensive patients, and combination product formulations with amlodipine or hydrochlorothiazide also consume significant volumes globally.
The Q2 2026 average was USD 70.5/KG in the United States, USD 48.9/KG in China, USD 86.7/KG in Germany, and USD 67.0/KG in India. Germany remains the highest-priced market.
The global average rose from USD 57.68/KG in Q1 to about USD 61.14/KG in Q2, a gain of around 6.0%. Recovering antihypertensive and nephropathy demand and firmer synthesis intermediate costs drove the H1 firming from the Q4 2025 correction.
Imidazole and biphenyltetrazole synthesis intermediate cost moderation eased the API production floor. Seasonal antihypertensive procurement moderation reduced buying urgency before the H1 2026 recovery.
The global average is expected in the USD 61.6 to 68.8/KG range for H2 2026, with continued firming as synthesis costs stay elevated and antihypertensive and nephropathy demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on antihypertensive demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to imidazole and biphenyltetrazole synthesis intermediate costs, antihypertensive prescribing cycles, and diabetic nephropathy management guideline adoption. Synthesis precursor prices and hypertension treatment access data are key signals.
China and India hold the largest olmesartan medoxomil API synthesis capacity. Any synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time antihypertensive formulation contracts around synthesis cost cycles, build cover when intermediate signals tighten, and monitor antihypertensive prescribing volumes as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
- Report in Excel Format
- 3 Months Price Forecast
- Historical Prices for the Past 3 Years
-
Summary Of Factors Influencing Prices
- Current Price Overview
- 3-Month Price Forecast
- Historical Price Summary
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Historical Price Trends
- Current Market Pricing
- 3-Month Price Forecast
- Grade / Specification-wise Pricing
- Pricing Data in Excel Format
- Pricing Summary
- Monthly Price Updates
- Regional Price Benchmarking
- Price Drivers & Market Influencing Factors
- Analyst Support for Pricing Insights
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.